Three Hospital Systems Earn Five-Star Ranking from Patient Safety Movement Foundation
18.9.2019 01:00:00 EEST | Business Wire | Press release
On the first World Patient Safety Day, the Patient Safety Movement Foundation (PSMF) announces that it has awarded Dignity Health, MedStar Health and the UPMC with its five-star ranking making commitments in alignment with PSMF’s 18 evidence-based Actionable Patient Safety Solutions (APSS). APSS include solutions designed to help hospitals eliminate preventable patient deaths. Preventable deaths are the third leading cause of death in the U.S.
“More than 200,000 patients die from preventable hospital errors in the U.S., and 4.8 million across the globe. Those numbers are simply not acceptable but also unthinkable,” said Dr. David Mayer, PSMF CEO. “Our 5-Star ranking acknowledges the commitment these organizations have made to achieve ZERO preventable deaths. The leadership demonstrated by these leaders is a model others can follow in instituting best practices in patient care.”
Dignity Health is the largest hospital provider in California with 39 hospitals, and part of the newly formed CommonSpirit Health, a nonprofit, Catholic health system dedicated to advancing health for all people. As part of CommonSpirit, Dignity Health continues to stand for excellent, affordable health care delivered with compassion.
“Dignity Health has been working to improve patient safety and clinical outcomes because we know what’s at stake—how critical this work is to the people who come to us for care,” said Robert Wiebe, MD, Chief Medical Officer for CommonSpirit Health. “We and other health systems strive to achieve zero preventable deaths, which is why we’ve implemented the APSS and many other initiatives.”
In keeping with the goals of the PSMF, Dignity Health has:
- Improved compliance with and adoption of the sepsis bundle and reduced sepsis mortality
- Reduced unnecessary cesarean sections for low risk deliveries
- Reduced hypoglycemia events
- Reduced hospital acquired infections
- Reduced opioid induced respiratory depression
- Achieved nearly full adoption of CANDOR across all Dignity Health hospitals and ambulatory settings
With 10 regional hospitals in Baltimore/Washington DC, MedStar Health earned its ranking for its role in the development of APSS in the areas of Culture of Safety, Falls and Fall Prevention, Patient and Family Engagement, Patient Safety Education and Early Detection of Sepsis.
Since implementing its patient safety improvement efforts, aligned with the PSMF APSS, MedStar Health has:
- Reduced the number of serious patient safety events
- Reduced the number of healthcare-associated infections
- Increased and improved front-line reporting of events
- Reduced the cost of care associated with serious safety events
- Improved the early detection and treatment of sepsis
“As we continually find ways to improve patient safety and clinical outcomes, we look to extend these practices to other healthcare systems around the World,” said Stephen R. T. Evans, MedStar Health Executive Vice President, Medical Affairs & Chief Medical Officer. “We are proud of our partnership with the Patient Safety Movement Foundation and its mission to eliminate preventable patient deaths in hospitals. Through the APSS shared-learning model, all healthcare systems can move from information to action.”
UPMC, one of the nation’s largest integrated payor-provider systems, includes more than 40 hospitals and 700 doctors’ offices and outpatient sites. UPMC has developed new models of accountable, cost-effective, patient-centered care. This focus aligns perfectly with PSMF APSS. Its goal is to deliver the right care, in the right way, at the right time to every patient.
“Our mission is to consistently provide high-quality, safe and compassionate patient experiences,” said Tami Minnier, UPMC chief quality officer. “We strive to be leaders in continually improving quality and safety through education, best practices, leadership development and innovation.”
That approach has resulted in significant quality and safety improvements for the health system, including a reduction in central line associated blood stream and C. diff infections, a 9 percent decrease in sepsis-related mortality, a nearly 30 percent increase in systemwide hand hygiene compliance and a 29 percent reduction in wasted blood products, thanks to a reduction in non-evidence based transfusions.
“We are delighted to see Dignity Health, MedStar Health, and UPMC health systems are joining CHOC, Hospital Espanol, Parish Medical and UCI to be the first to implement all Actionable Patient Safety Solutions,” said Joe Kiani, PSMF Founder and Chairman of the Board. “To err is human, but these evidence-based processes can avoid human errors from becoming fatal.”
More than 4,600 hospitals in 46 countries have implemented the Actionable Patient Safety Solutions developed by the Patient Safety Movement Foundation’s workgroups. For more information commitment to action or the Patient Safety Movement, please visit patientsafetymovement.org.
About Patient Safety Movement Foundation
Each year, more than 200,000 people die unnecessarily in U.S. hospitals. Worldwide, 4.8 million lives are similarly lost. The Patient Safety Movement Foundation (PSMF) is a global non-profit that offers free tools to help achieve ZERO preventable deaths from hospital errors. The Patient Safety Movement Foundation was established through the support of the Masimo Foundation for Ethics, Innovation, and Competition in Healthcare to reduce that number of preventable deaths to ZERO. Improving patient safety requires a collaborative effort from all stakeholders, including patients, healthcare providers, medical technology companies, government, employers, and private payers. PSMF’s World Patient Safety, Science & Technology Summit brings together the world’s best minds for thought-provoking discussions and new ideas to challenge the status quo. Our Actionable Patient Safety Solutions (APSS) provide evidence-based processes to help hospitals eliminate errors. Our Open Data Pledge encourages healthcare technology companies to share the data for which their products are purchased. Visit patientsafetymovement.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190917006134/en/
Contact information
David Kodama
Cook + Schmid
dkodama@cookandschmid.com
619-814-2370 x17
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alipay Launches Next-Generation AI Payment Infrastructure, Debuts AI Wallet and Token Pay to Power Agentic Economy26.5.2026 18:20:00 EEST | Press release
Alipay today introduced its full-stack AI payment solution to partners across industries, ranging from AI companies to traditional retailers, and debuted two new services — the world’s first AI Wallet and Token Pay — to support the agentic economy’s rapid growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526337824/en/ Alipay Unveils Next-generation AI Payment Infrastructure This launch extends Alipay's next-generation AI payment infrastructure, building on its consumer-facing product Alipay AI Pay and its business-facing AI payment processing product. “While the essence of commerce remains unchanged in the age of AI, the emergence of AI agents is reshaping everything. Drawing on 22 years of technological expertise and commercial know-how, Alipay is building a new generation of AI payment services to accelerate the growth of the agentic commerce ecosystem,” said Cyril Han, CEO of Ant Group. AI Wallet: Giving Users Vis
Daiichi Sankyo Europe Reaffirms Commitment to Patient-Centred Care with Extensive Data Showcase at EAS Congress 202626.5.2026 18:00:00 EEST | Press release
Daiichi Sankyo Europe (DSE) is pleased to announce its extensive scientific presence at the European Atherosclerosis Society (EAS) Congress 2026. The presentation of 15 abstracts, comprising both clinical trial analyses and real-world evidence, underscores the company's sustained investment in cardiovascular health and its mission to care for every heartbeat. The 15-abstract showcase provides a comprehensive look at the role of bempedoic acid in lipid management. This includes post-hoc analyses in collaboration with Esperion Therapeutics from the Phase 3 CLEAR Outcomes trial exploring its impact on stroke and venous thromboembolism (VTE) incidence.5,6 There are also real-world findings from the MILOS registry, including a dedicated sub-analysis investigating the effectiveness of bempedoic acid across various background therapies.1,2,3,4 Results reinforce consistent effectiveness and safety profile of bempedoic acid across various EU countries and regardless of patients’ existing treatm
OpenRouter Raises $113 Million CapitalG-led Series B as Weekly Volume Explodes to 25T Tokens26.5.2026 16:15:00 EEST | Press release
OpenRouter, the AI model exchange, today announced a $113 million Series B led by Alphabet’s independent growth fund, CapitalG, with participation from investors including NVentures (NVIDIA’s venture capital arm), ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures, alongside existing investors including Andreessen Horowitz and Menlo Ventures. OpenRouter’s volume has surged to 25 trillion tokens per week (100 trillion tokens per month), representing a 5X increase from the 5 trillion tokens processed per week just six months ago. The explosion in token demand illustrates how quickly enterprises are deploying agents and scaling AI across multiple models and providers. OpenRouter’s infrastructure manages and optimizes inference and provides access to 400+ models across leading AI providers, including Anthropic, Google, OpenAI, xAI, and DeepSeek, among others. The platform is used by over 8 million global users, including AI-native startups and large enterprises,
Xsolla Expands Its Community Management Tools for Creators, Community Leaders, and Resellers26.5.2026 16:00:00 EEST | Press release
Xsolla, a leading global video game commerce company, today announced three simultaneous expansions of its community management tools and products. As the creator economy continues to reshape how games are discovered and the industry accelerates its shift toward direct-to-consumer commerce, Xsolla is building on its community management tools for creators, community leaders, and emerging markets, and will showcase them at TwitchCon Rotterdam later this month. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526596720/en/ Graphic: Xsolla The games industry has never had a shortage of people who drive player acquisition, loyalty, and commerce; it's had a shortage of infrastructure that recognizes them. Creators stream it. Community leaders build a culture around it. Local resellers get it into the hands of players in markets traditional channels can't reach. Each operates at the center of how games are discovered, adopted, an
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 15:00:00 EEST | Press release
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
